CA2049274A1 - Flurbiprofen intermediates & processes - Google Patents
Flurbiprofen intermediates & processesInfo
- Publication number
- CA2049274A1 CA2049274A1 CA 2049274 CA2049274A CA2049274A1 CA 2049274 A1 CA2049274 A1 CA 2049274A1 CA 2049274 CA2049274 CA 2049274 CA 2049274 A CA2049274 A CA 2049274A CA 2049274 A1 CA2049274 A1 CA 2049274A1
- Authority
- CA
- Canada
- Prior art keywords
- cyano
- fluoro
- lower alkyl
- nitrophenyl
- propionic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims abstract description 32
- 230000008569 process Effects 0.000 title claims abstract description 29
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 title claims abstract description 22
- 229960002390 flurbiprofen Drugs 0.000 title abstract description 18
- 239000000543 intermediate Substances 0.000 title abstract description 10
- 238000006243 chemical reaction Methods 0.000 claims abstract description 15
- 125000005907 alkyl ester group Chemical group 0.000 claims abstract description 13
- JWIISSLCYOCFEG-UHFFFAOYSA-N 2-cyano-2-(3-fluoro-4-nitrophenyl)propanoic acid Chemical compound FC=1C=C(C=CC1[N+](=O)[O-])C(C(=O)O)(C)C#N JWIISSLCYOCFEG-UHFFFAOYSA-N 0.000 claims abstract 5
- -1 (2-fluoro-3-nitrophenyl)-2-cyano-propionic acid Chemical compound 0.000 claims description 13
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 claims description 10
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 230000000875 corresponding effect Effects 0.000 claims description 5
- RJXOVESYJFXCGI-UHFFFAOYSA-N 2,4-difluoro-1-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1F RJXOVESYJFXCGI-UHFFFAOYSA-N 0.000 claims description 4
- 239000002253 acid Substances 0.000 claims description 4
- 150000002148 esters Chemical class 0.000 claims description 4
- 150000004702 methyl esters Chemical class 0.000 claims description 2
- 150000001448 anilines Chemical class 0.000 claims 3
- 230000003301 hydrolyzing effect Effects 0.000 claims 2
- 125000004492 methyl ester group Chemical group 0.000 claims 2
- 229940018563 3-aminophenol Drugs 0.000 claims 1
- 230000001035 methylating effect Effects 0.000 claims 1
- 238000002360 preparation method Methods 0.000 abstract description 7
- 150000001875 compounds Chemical class 0.000 description 29
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 10
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 229910052739 hydrogen Inorganic materials 0.000 description 6
- 239000001257 hydrogen Substances 0.000 description 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 229960000583 acetic acid Drugs 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 125000004093 cyano group Chemical group *C#N 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 238000006114 decarboxylation reaction Methods 0.000 description 2
- VAYGXNSJCAHWJZ-UHFFFAOYSA-N dimethyl sulfate Chemical compound COS(=O)(=O)OC VAYGXNSJCAHWJZ-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 239000010410 layer Substances 0.000 description 2
- 150000002690 malonic acid derivatives Chemical class 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- GWHHQWUYMDWMAY-UHFFFAOYSA-N methyl 2-cyanopropanoate Chemical compound COC(=O)C(C)C#N GWHHQWUYMDWMAY-UHFFFAOYSA-N 0.000 description 2
- ANGDWNBGPBMQHW-UHFFFAOYSA-N methyl cyanoacetate Chemical compound COC(=O)CC#N ANGDWNBGPBMQHW-UHFFFAOYSA-N 0.000 description 2
- 238000010534 nucleophilic substitution reaction Methods 0.000 description 2
- 229910052697 platinum Inorganic materials 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 2
- GALSVFOXBFKMEG-UHFFFAOYSA-N 2-(3-fluoro-4-nitrophenyl)propanoic acid Chemical compound OC(=O)C(C)C1=CC=C([N+]([O-])=O)C(F)=C1 GALSVFOXBFKMEG-UHFFFAOYSA-N 0.000 description 1
- JDEFPFLTCXIVDH-UHFFFAOYSA-N 2-cyanopropanoic acid Chemical compound N#CC(C)C(O)=O JDEFPFLTCXIVDH-UHFFFAOYSA-N 0.000 description 1
- QISHNBUAHFMREY-UHFFFAOYSA-N 3-(4-aminophenoxy)-3-oxopropanoic acid Chemical class NC1=CC=C(OC(=O)CC(O)=O)C=C1 QISHNBUAHFMREY-UHFFFAOYSA-N 0.000 description 1
- ROEDZLANUGSHES-UHFFFAOYSA-N 3-(4-nitrophenoxy)-3-oxopropanoic acid Chemical class OC(=O)CC(=O)OC1=CC=C([N+]([O-])=O)C=C1 ROEDZLANUGSHES-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- OIFBSDVPJOWBCH-UHFFFAOYSA-N Diethyl carbonate Chemical compound CCOC(=O)OCC OIFBSDVPJOWBCH-UHFFFAOYSA-N 0.000 description 1
- IYXGSMUGOJNHAZ-UHFFFAOYSA-N Ethyl malonate Chemical compound CCOC(=O)CC(=O)OCC IYXGSMUGOJNHAZ-UHFFFAOYSA-N 0.000 description 1
- 238000005903 acid hydrolysis reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 238000005904 alkaline hydrolysis reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 239000011260 aqueous acid Substances 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- QRZAKQDHEVVFRX-UHFFFAOYSA-N biphenyl-4-ylacetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1C1=CC=CC=C1 QRZAKQDHEVVFRX-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- GAFINJXANQZOKT-UHFFFAOYSA-N cyano acetate Chemical group CC(=O)OC#N GAFINJXANQZOKT-UHFFFAOYSA-N 0.000 description 1
- NGLOXYOGEMWSOD-UHFFFAOYSA-N cyano propanoate Chemical compound CCC(=O)OC#N NGLOXYOGEMWSOD-UHFFFAOYSA-N 0.000 description 1
- 238000006193 diazotization reaction Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960000192 felbinac Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 150000004678 hydrides Chemical class 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- OWFXIOWLTKNBAP-UHFFFAOYSA-N isoamyl nitrite Chemical compound CC(C)CCON=O OWFXIOWLTKNBAP-UHFFFAOYSA-N 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012022 methylating agents Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000000269 nucleophilic effect Effects 0.000 description 1
- 239000012044 organic layer Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000012258 stirred mixture Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
 ABSTRACT OF THE DISCLOSURE
 
There are provided 2-(3-fluoro-4-nitrophenyl)-cyano-propionic acid lower alkyl esters, useful as inter-mediates in the preparation of flurbiprofen, as well as processes for their preparation and processes for their conversion to flurbiprofen.
  There are provided 2-(3-fluoro-4-nitrophenyl)-cyano-propionic acid lower alkyl esters, useful as inter-mediates in the preparation of flurbiprofen, as well as processes for their preparation and processes for their conversion to flurbiprofen.
Description
 2~27~
 
This invention relates to flurbiprofen and methods for its preparation. More particularly, it relates to novel intermediates useful in the synthesis o~ flurbi-profen, processes for preparing such novel intermediates and use of the intermediates in preparation of flurbi-profen.
 
Flurbiprofen, which is chemically 2-(2-fluoro-4-biphenylyl) propionic acid o~ the formula:
~,j ~lo O ~ 3 F
 
is a well-known and well accepted pharmaceutical, commonly prescribed as an anti-in~lammatory, analgesic and anti-pyretic. It is described in Canadian patent 831 J 029 Adams et al., issued December 30, 1969. It continues to be of major importance as a human medicine, and so there is a continuing incentive to devise improved commercial methods for its synthesis and production.
 
Aforementioned Canadian patent 831,029 describes the preparation o~ flurbiprofen and its analogs from biphenyl and its derivatives. One such process is the reaction of an ester o~ a 4-biphenylyl acetic acid with diethyl carbonate and sodium ethoxide followed by hydroly-sis o~ the malonic ester which is formed and decarboxyla-tion of the resulting malonic compound by heating. Another process disclosed therein is the reduction of the corre-sponding ~-hydroxy acid.
 
U.S. patents 4,266,069 and 4,398,035 Walker, which are essentially identical to one another as regards their technical teachings, describe higher yield processes 2~27'~
 
for making flurbiprofen, utili~ing as inte~mediates malonic acid or dialkyl malonate compounds of the formula /c ~o~
~,C - C ~ c og R~
 
1`1 ~1 where R is hydrogen or lower alkylO These compounds can be coupled to benzene by means of the Gomberg-Bachmann reaction to form biphenylyl compounds, followed by decar-boxylation to the desired biphenylyl-propionic acid com-pounds. Unexpectedly high yields of biphenylyl compounds from the coupling reaction are claimed in these patents.
Howaver, the specific compound used in flurbiprofen prep-aration according to thi~ process, methyl-(4-amino~3-flurophenyl)-2-cyano propionate, i5 an air-unstable oil which quickly darkens. In the process described therein, the p-aminophenyl malonate compounds are prepared by reduction of the corresponding p-nitrophenyl malonate compounds, which in turn are prepared by reaction of dialkyl malonates with l-chloro-3-fluoro-4-nitrobenzene in the presence of a base.
 
It is an object of the present invention to provide novel processes for preparing flurbiprofen, and novel intermediates for use in such processes.
 
It is a ~urther object of the present invention to provide processes for making such novel intermediates.
 
., .
.
 
2 0 ll 9 2 1 ll According to a first aspect, the present inven-tion provides, as novel compounds useful as intermediates in flurbiprofen synthesis, 2-(3-fluoro-~-nitrophenyl~ 2-cyano propionic acid lower alkyl esters, and their 4-amino analogs.
 
According to another aspect, there is provided a process of preparing 2-(2-fluoro-3-nitrophenyl)-2-cyano propionic acid lower alkyl esters, which comprises reacting 2,4-difluoro nitrobenzene with a lower alkyl-~2-cyano) propionate.
 
According to a further aspect, there are provided processes of converting the novel intermediates defined above to flurbiprofen.
 
The term 'llower alkyl" as used herein, in connec-tion with the propionic esters, means Cl C4 alkyl groups.
Most preferred among these is methyl, and so the invention will be described below with reference to the methyl esters thereof.
 
The accompanying single Figure of drawings is a diagrammatic process flow sheet illustrating the chemical compounds of the present invention and the preferred processes for their preparation and use.
 
With reference to the Figure, the starting material for the preferred process of the present inven-tion, compound (I) is 2-4-difluoro nitrobenzene, a commer-cially available compound. This is chemically converted to methyl-[2-(3--fluoro-4-nitro)-2 cyano]propionate, compound (II), by one of two processes. It may be converted direct-ly, by reaction with methyl-2-cyano propionate~ in solution in an aprotic solvent such as dimethylEormamide under alkaline conditions. Alternatively, compound (I) is first 7 ~
 
reacted with methyl cyano acetate under similar conditions, to effect nucleophilic substitukion of the 4-fluoro group of compound (I) with the cyano acetate group through position 2 thereof. This product is then extractad and subsequently reacted wi~h a methylating agent such as dimethyl sulphate to form methyl ~-(3-fluoro-4-nitro-phenyl)-2-cyano propionate, compound (II).
 
This compound (II) is a novel compound, and constitutes a principle feature of the present invention.
Nucleophilic substitution of the appropriate fluorine group with compounds carrying a cyano group and an ester group attached to the same carbon atom proceed just as readily as nucleophilic substitution of compounds bearing two ester groups as used in the aforementioned process shown in the Walker patents. Certain unexpected advantages flow from the use of these cyano intermediates of the present inven-tion, as one proceeds to the synthesis of flurbiprofen from them.
For example, in the preferred process of the present invention, compound (II) is next converted to compound (III), its amino analog, by hydrogenation, e.g.
with hydrogen over a platinum catalyst. This compound (III) methyl 2-(4-amino-3-flurophenyl)-2~-cyano propionate, is a readily recrystallizabl~, high melting white solid, easy to purify and stable. In contrast, the corresponding dimethyl malonate compound is an air-unstable oil, diffi~
cult to extract and purify, and subject to rapid darkening in air. Compound (III) as shown in the accompanying draw-ing, on the other hand, can be dried under vacuum at 50C, and stored for future use.
 
The next step o~ the pre~erred synthesis is the conversion of compound (III) to methyl 2-(2-fluoro-bipheny lyl)=2-cyano propionate, compound (IV). This is done by 2 ~L~ 9 2 ~ '~
 
making use of the Gomberg-Bachmann reaction, which involves diazotization of the amino group using an alkyl nitrite, followed by reaction with benzene~ A description of the Gomberg-Bachmann reaction can be found in "Advanced Organic Chemistry: Reactions Mechanisms and Structure," pages 550-551, 1968 (McGraw-Hill, Inc.), an article by March.
 
Compound (IV) resulting from the Gomberg-Bachmann reaction, can then be refluxed with aqueous acid or with aqueous alkali to convert it to the free acid, flurbi-profen, compound (V).
 
An alternative process according to the present invention first converts compound (II) to 2-(3-fluoro-4-nitrophenyl) propionic acid, compound (VI) by acid or alka-line hydrolysis. Then compound (VI) can be hydrogenated to form the 4-amino analog, compound (VII), using hydrogen over a platinum catalyst. Then compound (VII) can be subjected to the Gomberg-Bachmann reaction as described above to form flurbiprofen, compound (IV).
 
The invention is further described for illustra-tive purposes in the following specific examples.
 
~5 EXAMPLE 1 - METHYL 2-(3-FLUORO-4-NITROPHENYL)-2-CYANO
ACETATE
 
To a stirred mixture of 100 g (0.63 mole) of 2,4-difluoro nitroben~ene and 75 g (0.75 mole~ of methyl cyano acetate in 750 ml of dimethyl formamide at 0-10C and under an atmosphere of nitrogen, was added 65g (1~6 mole) of sodium hydroxide. After allowing to rise to room tempera~-ture, the reaction mixture was stirred overnight (about 16 hours). 1500 ml of water was added and the mixture acidified with dilute mineral acid to a pH of 2-3. The mixture was extracted with three lots of 500 ml ethyl 2 ~
 
acetate. The combined extracts were washed with several portions of dilute aqueous sodium sulphate and dried over sodium sulphate. Concentration under vacuo gave 150 g of oil.
 
EXAMPLE 2 - M~THYL 2-(3-FLUOKO-4 NITROPHENYL)-2 CYANO
PROPIONATE
 
A solution of 20g (84 mol) of methyl 2-(3-fluoro-4-nitrophenyl)-2-cyano acetate in ~0 ml of dry tetrahydro-furan was added drop-wise to a suspension of 5.0 g (0.125 mole) of 60~ oil-dispersed sodium hydroxide in 280 ml of tetrahydrofuran at 0C and under an atmosphere of nitrogen.
After evolution o~ hydrogen stopped, 12 g (0.095 mole) of dimethylsulfate was added. The mixture was heated to reflux for 8 hours and cooled in an ice-bath. Excess hydride was destroyed with some methanol. Aqueous 5%
sulfuric acid was added and the mixture extracted with ethyl acetate. The combined extracts were dried over sodium sulfate and concentrated under vacuo to give crude methyl 2-(3-fluoro-4-nitrophenyl)-2-cyano propionate.
 
EXAMPLE 3 - METHYL 2-(3-FLUORO-4-NITROPHENYL)-2-CYANO
PROPIONATE - alternate method 2.8g (17.6 mmole) of 2,4-difluoronitrobenzene and 2.0g (17.7mmole) of methyl 2-cyanopropionate wreradded to 25 ml of dimethylformamid~ and cooled in an ice-bath. With vigourous stirring and under an atmosphere of nitrogen, 0.85g (21.3mmole) of sodium hydroxide was added. The mixture was stirred for 30 minutes in the ice-bath and then the ice-bath was removed. The reaction was then stirred overnight at room temperature. 20 ml of water was added and the mixture was extracted with 2x100 ml ethyl acetateO The organic layers were combined and washed with saturated aqueous sodium sulphate solution, dried over sodium sul-phate and concentrated under vacuo to give an oil.
 
. - ~ ' ~ ' EXAMPLE 4 - METHYL 2-(4-AMINO-3-FLUOROPHENYL)-2-CYANO
PROPIONATE __ _ A mixture of 24 g of crude methyl 2-(3-fluoro-4-nitrophenyl)-2-cyano propionate and 1.9 g of 5~ platinum-on-carbon catalyst in 200 ml of methanol was hydrogenated in a parr vessel at 20 - 25 psi of hydrogen pressure.
After the required amount of hydrogen was consumed, the reaction mixture filter and the filtrate concentrated under vacuo to give 21 g of an air-stable solid melting poink above 207C (decomposed).
 
EXAMPLE 5 - METHYL 2-(2-FLUORO-4-BIPHENYLYL)-2-CYANO
PROPIONATE
22g (99 mmol) of methyl 2-(4-amino-3-fluorophen-yl)-2-cyanopropionate was suspended in 600 ml of benzene and heated to 35 - 40C in an oil-bath. Then a solution of 35g (0.3mole) of isoamyl nitrite in 200 ml benzene was added dropwise over 1-2 hours. After the addition, the mixture was heated to 65 - 70C for 30 minutes and cooled to room temperature. Benzene was removed under vacuo to give a residue. Several portions of toluene were added and successively concentrated under vacuo. The resulting residue was triturated with a mixture of ethyl acetate and hexane to give a solid, m. pt. 186 - 189C.
 
EXAMPLE 6 - 2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID
(FLURBIPROF~N~ _ (a) A mixture containing 16 g of crude methyl 2-(2-fluoro-4-biphenylyl)-2-cyano propionate, 100 ml of 6N
aqueous hydrochloric acid and lOO ml of glacial acetic acid was refluxed under nitrogen for 30 hours. After cooling with an icebath (approximately 10C), the mixture was ~.
 
2~2~
- 8 ~
 
adjusted to pH 8.5 with 4N aqueous hydroxide and extracted with two lots of 100 ml methylene chloride. The aqueous layer was acidified with concentrated hydrochloric acid to pH 1-2 and cooled in a bath maintained at 5C with stir-ring. The precipitate was collected by filtration. The crude flurbiprofen was recrystalli~ed from aqueous acetic acid to give 11 g of solid.
 
(b) 10 g of methyl 2-(2-fluoro-4-biphenylyl) 2-cyano propionate was dissolved in 40 ml of ethanol. Then 30 g of 50% aqueous sodium hydroxide was added. The mixture was refluxed for 48 hours after diluting with 50 ml of water, the pH was adjusted to 8.5 and extracted with two lots of 100 ml methylene chloride. The a~ueous layer was acidified to pH below 2.0 and the precipitate was collected.
Recrystallization form aqueous acetic acid gave 6.6 g of flurbiprofen.
 
.
'
    This invention relates to flurbiprofen and methods for its preparation. More particularly, it relates to novel intermediates useful in the synthesis o~ flurbi-profen, processes for preparing such novel intermediates and use of the intermediates in preparation of flurbi-profen.
Flurbiprofen, which is chemically 2-(2-fluoro-4-biphenylyl) propionic acid o~ the formula:
~,j ~lo O ~ 3 F
is a well-known and well accepted pharmaceutical, commonly prescribed as an anti-in~lammatory, analgesic and anti-pyretic. It is described in Canadian patent 831 J 029 Adams et al., issued December 30, 1969. It continues to be of major importance as a human medicine, and so there is a continuing incentive to devise improved commercial methods for its synthesis and production.
Aforementioned Canadian patent 831,029 describes the preparation o~ flurbiprofen and its analogs from biphenyl and its derivatives. One such process is the reaction of an ester o~ a 4-biphenylyl acetic acid with diethyl carbonate and sodium ethoxide followed by hydroly-sis o~ the malonic ester which is formed and decarboxyla-tion of the resulting malonic compound by heating. Another process disclosed therein is the reduction of the corre-sponding ~-hydroxy acid.
U.S. patents 4,266,069 and 4,398,035 Walker, which are essentially identical to one another as regards their technical teachings, describe higher yield processes 2~27'~
for making flurbiprofen, utili~ing as inte~mediates malonic acid or dialkyl malonate compounds of the formula /c ~o~
~,C - C ~ c og R~
1`1 ~1 where R is hydrogen or lower alkylO These compounds can be coupled to benzene by means of the Gomberg-Bachmann reaction to form biphenylyl compounds, followed by decar-boxylation to the desired biphenylyl-propionic acid com-pounds. Unexpectedly high yields of biphenylyl compounds from the coupling reaction are claimed in these patents.
Howaver, the specific compound used in flurbiprofen prep-aration according to thi~ process, methyl-(4-amino~3-flurophenyl)-2-cyano propionate, i5 an air-unstable oil which quickly darkens. In the process described therein, the p-aminophenyl malonate compounds are prepared by reduction of the corresponding p-nitrophenyl malonate compounds, which in turn are prepared by reaction of dialkyl malonates with l-chloro-3-fluoro-4-nitrobenzene in the presence of a base.
It is an object of the present invention to provide novel processes for preparing flurbiprofen, and novel intermediates for use in such processes.
It is a ~urther object of the present invention to provide processes for making such novel intermediates.
., .
.
2 0 ll 9 2 1 ll According to a first aspect, the present inven-tion provides, as novel compounds useful as intermediates in flurbiprofen synthesis, 2-(3-fluoro-~-nitrophenyl~ 2-cyano propionic acid lower alkyl esters, and their 4-amino analogs.
According to another aspect, there is provided a process of preparing 2-(2-fluoro-3-nitrophenyl)-2-cyano propionic acid lower alkyl esters, which comprises reacting 2,4-difluoro nitrobenzene with a lower alkyl-~2-cyano) propionate.
According to a further aspect, there are provided processes of converting the novel intermediates defined above to flurbiprofen.
The term 'llower alkyl" as used herein, in connec-tion with the propionic esters, means Cl C4 alkyl groups.
Most preferred among these is methyl, and so the invention will be described below with reference to the methyl esters thereof.
The accompanying single Figure of drawings is a diagrammatic process flow sheet illustrating the chemical compounds of the present invention and the preferred processes for their preparation and use.
With reference to the Figure, the starting material for the preferred process of the present inven-tion, compound (I) is 2-4-difluoro nitrobenzene, a commer-cially available compound. This is chemically converted to methyl-[2-(3--fluoro-4-nitro)-2 cyano]propionate, compound (II), by one of two processes. It may be converted direct-ly, by reaction with methyl-2-cyano propionate~ in solution in an aprotic solvent such as dimethylEormamide under alkaline conditions. Alternatively, compound (I) is first 7 ~
reacted with methyl cyano acetate under similar conditions, to effect nucleophilic substitukion of the 4-fluoro group of compound (I) with the cyano acetate group through position 2 thereof. This product is then extractad and subsequently reacted wi~h a methylating agent such as dimethyl sulphate to form methyl ~-(3-fluoro-4-nitro-phenyl)-2-cyano propionate, compound (II).
This compound (II) is a novel compound, and constitutes a principle feature of the present invention.
Nucleophilic substitution of the appropriate fluorine group with compounds carrying a cyano group and an ester group attached to the same carbon atom proceed just as readily as nucleophilic substitution of compounds bearing two ester groups as used in the aforementioned process shown in the Walker patents. Certain unexpected advantages flow from the use of these cyano intermediates of the present inven-tion, as one proceeds to the synthesis of flurbiprofen from them.
For example, in the preferred process of the present invention, compound (II) is next converted to compound (III), its amino analog, by hydrogenation, e.g.
with hydrogen over a platinum catalyst. This compound (III) methyl 2-(4-amino-3-flurophenyl)-2~-cyano propionate, is a readily recrystallizabl~, high melting white solid, easy to purify and stable. In contrast, the corresponding dimethyl malonate compound is an air-unstable oil, diffi~
cult to extract and purify, and subject to rapid darkening in air. Compound (III) as shown in the accompanying draw-ing, on the other hand, can be dried under vacuum at 50C, and stored for future use.
The next step o~ the pre~erred synthesis is the conversion of compound (III) to methyl 2-(2-fluoro-bipheny lyl)=2-cyano propionate, compound (IV). This is done by 2 ~L~ 9 2 ~ '~
making use of the Gomberg-Bachmann reaction, which involves diazotization of the amino group using an alkyl nitrite, followed by reaction with benzene~ A description of the Gomberg-Bachmann reaction can be found in "Advanced Organic Chemistry: Reactions Mechanisms and Structure," pages 550-551, 1968 (McGraw-Hill, Inc.), an article by March.
Compound (IV) resulting from the Gomberg-Bachmann reaction, can then be refluxed with aqueous acid or with aqueous alkali to convert it to the free acid, flurbi-profen, compound (V).
An alternative process according to the present invention first converts compound (II) to 2-(3-fluoro-4-nitrophenyl) propionic acid, compound (VI) by acid or alka-line hydrolysis. Then compound (VI) can be hydrogenated to form the 4-amino analog, compound (VII), using hydrogen over a platinum catalyst. Then compound (VII) can be subjected to the Gomberg-Bachmann reaction as described above to form flurbiprofen, compound (IV).
The invention is further described for illustra-tive purposes in the following specific examples.
~5 EXAMPLE 1 - METHYL 2-(3-FLUORO-4-NITROPHENYL)-2-CYANO
ACETATE
To a stirred mixture of 100 g (0.63 mole) of 2,4-difluoro nitroben~ene and 75 g (0.75 mole~ of methyl cyano acetate in 750 ml of dimethyl formamide at 0-10C and under an atmosphere of nitrogen, was added 65g (1~6 mole) of sodium hydroxide. After allowing to rise to room tempera~-ture, the reaction mixture was stirred overnight (about 16 hours). 1500 ml of water was added and the mixture acidified with dilute mineral acid to a pH of 2-3. The mixture was extracted with three lots of 500 ml ethyl 2 ~
acetate. The combined extracts were washed with several portions of dilute aqueous sodium sulphate and dried over sodium sulphate. Concentration under vacuo gave 150 g of oil.
EXAMPLE 2 - M~THYL 2-(3-FLUOKO-4 NITROPHENYL)-2 CYANO
PROPIONATE
A solution of 20g (84 mol) of methyl 2-(3-fluoro-4-nitrophenyl)-2-cyano acetate in ~0 ml of dry tetrahydro-furan was added drop-wise to a suspension of 5.0 g (0.125 mole) of 60~ oil-dispersed sodium hydroxide in 280 ml of tetrahydrofuran at 0C and under an atmosphere of nitrogen.
After evolution o~ hydrogen stopped, 12 g (0.095 mole) of dimethylsulfate was added. The mixture was heated to reflux for 8 hours and cooled in an ice-bath. Excess hydride was destroyed with some methanol. Aqueous 5%
sulfuric acid was added and the mixture extracted with ethyl acetate. The combined extracts were dried over sodium sulfate and concentrated under vacuo to give crude methyl 2-(3-fluoro-4-nitrophenyl)-2-cyano propionate.
EXAMPLE 3 - METHYL 2-(3-FLUORO-4-NITROPHENYL)-2-CYANO
PROPIONATE - alternate method 2.8g (17.6 mmole) of 2,4-difluoronitrobenzene and 2.0g (17.7mmole) of methyl 2-cyanopropionate wreradded to 25 ml of dimethylformamid~ and cooled in an ice-bath. With vigourous stirring and under an atmosphere of nitrogen, 0.85g (21.3mmole) of sodium hydroxide was added. The mixture was stirred for 30 minutes in the ice-bath and then the ice-bath was removed. The reaction was then stirred overnight at room temperature. 20 ml of water was added and the mixture was extracted with 2x100 ml ethyl acetateO The organic layers were combined and washed with saturated aqueous sodium sulphate solution, dried over sodium sul-phate and concentrated under vacuo to give an oil.
. - ~ ' ~ ' EXAMPLE 4 - METHYL 2-(4-AMINO-3-FLUOROPHENYL)-2-CYANO
PROPIONATE __ _ A mixture of 24 g of crude methyl 2-(3-fluoro-4-nitrophenyl)-2-cyano propionate and 1.9 g of 5~ platinum-on-carbon catalyst in 200 ml of methanol was hydrogenated in a parr vessel at 20 - 25 psi of hydrogen pressure.
After the required amount of hydrogen was consumed, the reaction mixture filter and the filtrate concentrated under vacuo to give 21 g of an air-stable solid melting poink above 207C (decomposed).
EXAMPLE 5 - METHYL 2-(2-FLUORO-4-BIPHENYLYL)-2-CYANO
PROPIONATE
22g (99 mmol) of methyl 2-(4-amino-3-fluorophen-yl)-2-cyanopropionate was suspended in 600 ml of benzene and heated to 35 - 40C in an oil-bath. Then a solution of 35g (0.3mole) of isoamyl nitrite in 200 ml benzene was added dropwise over 1-2 hours. After the addition, the mixture was heated to 65 - 70C for 30 minutes and cooled to room temperature. Benzene was removed under vacuo to give a residue. Several portions of toluene were added and successively concentrated under vacuo. The resulting residue was triturated with a mixture of ethyl acetate and hexane to give a solid, m. pt. 186 - 189C.
EXAMPLE 6 - 2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID
(FLURBIPROF~N~ _ (a) A mixture containing 16 g of crude methyl 2-(2-fluoro-4-biphenylyl)-2-cyano propionate, 100 ml of 6N
aqueous hydrochloric acid and lOO ml of glacial acetic acid was refluxed under nitrogen for 30 hours. After cooling with an icebath (approximately 10C), the mixture was ~.
2~2~
- 8 ~
adjusted to pH 8.5 with 4N aqueous hydroxide and extracted with two lots of 100 ml methylene chloride. The aqueous layer was acidified with concentrated hydrochloric acid to pH 1-2 and cooled in a bath maintained at 5C with stir-ring. The precipitate was collected by filtration. The crude flurbiprofen was recrystalli~ed from aqueous acetic acid to give 11 g of solid.
(b) 10 g of methyl 2-(2-fluoro-4-biphenylyl) 2-cyano propionate was dissolved in 40 ml of ethanol. Then 30 g of 50% aqueous sodium hydroxide was added. The mixture was refluxed for 48 hours after diluting with 50 ml of water, the pH was adjusted to 8.5 and extracted with two lots of 100 ml methylene chloride. The a~ueous layer was acidified to pH below 2.0 and the precipitate was collected.
Recrystallization form aqueous acetic acid gave 6.6 g of flurbiprofen.
.
'
Claims (11)
1.        2-(3-fluoro-4-nitrophenyl)-2-cyano-propionic acid lower alkyl esters. 
    2.      Methyl-[2-(3-fluoro-4-nitrophenyl)-2-cyano]propionate. 
    3.      Methyl-[2-(3-fluoro-4-aminophenyl)-2-cyano] propionate. 
    4.      A process of preparing 2 (2-fluoro-3-nitrophenyl)-2-cyano-propionic acid lower alkyl  esters, which comprises reacting a 2,4-difluoro nitrobenzene with a lower alkyl-(2-cyano) propionate. 
    5.        The process of claim 4 wherein the lower alkyl -(2-cyano) propionate is methyl-(2-cyano) propionate. 
    6.        A   process   of   preparing  2-(3-fluoro-4-nitrophenyl)-2-cyano-propionic acid lower alkyl  esters, which comprises reacting 2,4-difluoro nitrobenzene with 2-cyano acetic (lower alkyl) ester to form 2-(3-fluoro-4-nitrophenyl) 2-cyano  acetic  (lower  alkyl)  ester,  and subsequently methylating the 2- position to form 2-(3-fluoro-4-nitrophenyl)-2-cyano propionic acid lower alkyl ester. 
    7.        The process of claim 6 wherein said lower alkyl ester is a methyl ester. 
    8.        A process of preparing 2-(2-fluoro-4-biphenylyl) propionic acid, which comprises: 
 
reducing a 2-(3-fluoro-4-nitrophenyl)-2-cyano-propionic acid lower alkyl ester to the corresponding aniline derivative;
 
converting the aniline derivative so formed through the Gomberg-Bachmann reaction to form a 2-(2-fluoro-4-biphenylyl)-2-cyano propionic acid lower alkyl ester:
 
and hydrolysing the lower alkyl cyano-ester to form the free acid.
    reducing a 2-(3-fluoro-4-nitrophenyl)-2-cyano-propionic acid lower alkyl ester to the corresponding aniline derivative;
converting the aniline derivative so formed through the Gomberg-Bachmann reaction to form a 2-(2-fluoro-4-biphenylyl)-2-cyano propionic acid lower alkyl ester:
and hydrolysing the lower alkyl cyano-ester to form the free acid.
9.        The process of claim 8 wherein the lower alkyl ester is the methyl ester. 
    10. A process of praparing 2-(2-fluoro-4-biphenylyl) propionic acid, which comprises hydrolysing a 2-(2-fluoro-3-nitrophenyl)-2-cyano-propionic acid lower alkyl ester to form 2-(2-fluoro-3-nitrophenyl) propionic acid;
 
reducing said nitrophenyl compound to the corre-sponding aniline derivative;
 
and converting the 3-amino phenol compound so formed through the Gomberg-Bachmann reaction to form 2-(2-fluoro-4-biphenylyl) propionic acid.
    reducing said nitrophenyl compound to the corre-sponding aniline derivative;
and converting the 3-amino phenol compound so formed through the Gomberg-Bachmann reaction to form 2-(2-fluoro-4-biphenylyl) propionic acid.
11.       The process of claim 10 wherein the lower alkyl ester is a methyl ester. 
    Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| CA 2049274 CA2049274A1 (en) | 1991-08-15 | 1991-08-15 | Flurbiprofen intermediates & processes | 
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| CA 2049274 CA2049274A1 (en) | 1991-08-15 | 1991-08-15 | Flurbiprofen intermediates & processes | 
Publications (1)
| Publication Number | Publication Date | 
|---|---|
| CA2049274A1 true CA2049274A1 (en) | 1993-02-16 | 
Family
ID=4148189
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| CA 2049274 Abandoned CA2049274A1 (en) | 1991-08-15 | 1991-08-15 | Flurbiprofen intermediates & processes | 
Country Status (1)
| Country | Link | 
|---|---|
| CA (1) | CA2049274A1 (en) | 
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| CN109651155A (en) * | 2017-10-11 | 2019-04-19 | 浙江瑞博制药有限公司 | Ketone ibuprofen intermediate and preparation method and application thereof | 
- 
        1991
        - 1991-08-15 CA CA 2049274 patent/CA2049274A1/en not_active Abandoned
 
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| CN109651155A (en) * | 2017-10-11 | 2019-04-19 | 浙江瑞博制药有限公司 | Ketone ibuprofen intermediate and preparation method and application thereof | 
Similar Documents
| Publication | Publication Date | Title | 
|---|---|---|
| CN102627573B (en) | Synthesis method for 5-aminolevulinic acid hydrochloride | |
| CA1127177A (en) | Phenylacetic acid derivatives | |
| US4824953A (en) | Multi-step process for producing 5-hydroxy-N-(6-oxo-piperidyl-methyl)-2-(2,2,2-trifluoro-ethoxy)-benzamide and derivatives | |
| JP2020026424A (en) | Method for synthesizing diclofenac sodium | |
| EP1881963B1 (en) | Process for the preparation of a carboxamide derivative | |
| US3362988A (en) | Alkanoylnaphthyloxy-carboxylic acids | |
| US4978773A (en) | Process for the preparation of 2,6-dichlorodiphenylaminoacetic acid derivatives | |
| CA2049274A1 (en) | Flurbiprofen intermediates & processes | |
| JP6702623B2 (en) | Method for preparing compounds such as 3-arylbutanal useful in the synthesis of medetomidine | |
| US4317920A (en) | Arylacetic acid derivatives | |
| CN115626879B (en) | Preparation method of 2-phenylpropionamido-benzoic acid derivative | |
| HU229188B1 (en) | Process for the preparation of n-[(s)-1-carboxybutyl]-(s)-alanine esters and their use for synthesizing perindopril | |
| JP3663229B2 (en) | Process for producing 4-halo-2'-nitrobutyrophenone compound | |
| US4324904A (en) | Processes for the preparation of hydratropic acids and esters | |
| US4266069A (en) | Processes for the preparation of hydratropic acids and esters | |
| CN106316837B (en) | Preparation method of substituted phenylacetic acid derivative | |
| US4231962A (en) | 3-Phenoxybenzylideneamines and 3-benzylbenzylideneamines | |
| JP4023697B2 (en) | Method for producing naphthalene derivative | |
| NO20025652L (en) | Process for the preparation of trifluoroethoxy-substituted benzoic acids | |
| US4080505A (en) | α-Chlorocarboxylic acids | |
| US4891433A (en) | Process for the preparation of dibenzothiepin derivative | |
| US5274100A (en) | Process for the preparation of (3-fluoropyridin-2-yloxy)phenoxypropionic acids | |
| CN117402085B (en) | Novel method for synthesizing D-N-BOC-biphenylpropylamine | |
| JP2536756B2 (en) | 5-alkoxyanthranilic acid ester | |
| US4385004A (en) | Esters of ortho-allylphenol useful for the preparation of arylacetic acid derivatives | 
Legal Events
| Date | Code | Title | Description | 
|---|---|---|---|
| FZDE | Dead |